Will oral weight loss drugs challenge injectables? | Business

Why are companies working so hard to make oral tablet forms of diabetes and weight loss drugs that target the glucagon-like peptide (GLP-1) receptor? The current injectable peptides – Novo Nordisk’s Ozempic and Wegovy (semaglutide) and Eli…